Welcome to the Maine Drug Data Hub
The Maine Drug Data Hub contains nearly 300 data metrics, nearly 200 reports and resources, as well as dozens of dashboards, maps, and other data products. Use the following navigation buttons to assist in your exploration of substance use and substance use disorder data and help you find what you are looking for. Need assistance? Email: firstname.lastname@example.org.
Maine Drug Data Hub recent data additions and updates
Data update 6-1-2023: The Maine Monthly Overdose Report for April 2023 has been released.
Data update 5-24-2023: The OPTIONS Initiative Project-to-Date Monthly Report for March 2023 has been released.
OPTIONS Initiative Project-to-Date Totals through March 31, 2023
Data update 5-23-2023: The Maine Naloxone Distribution Initiative Quarter 1 2023 Report has been released.
Maine Naloxone Distribution Initiative, Project-to-Date Totals through March 31, 2023.
or email email@example.com
Recent substance use related press releases
Governor Mills announces nearly $2 million to expand substance use disorder treatment in rural Maine
For additional press releases regarding substance use disorder, the opioid epidemic, or related social determinants of health please visit the Newsroom of the Office of Governor Janet T. Mills or News & Reports from the Office of the Maine Attorney General.
The Maine Drug Data Hub is a collaboration between several state departments, the Governor’s Office and the University of Maine. The aggregation of state and community information on the hub provides resources, data, and visualizations to inform Mainers about efforts to reduce the harm caused by drug use and drug overdose as well as to track progress towards reaching the goals outlined in Maine’s Opioid Response Strategic Action Plan.
The data, information, and resources available on the Maine Drug Data Hub is constantly being updated. Data sets, reports, and graphics are updated monthly, quarterly, and annually. New data metrics are added as they become available.
The Maine Drug Data Hub is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of an Overdose Data to Action (OD2A) cooperative agreement. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS or the U.S. Government.